Flyer

Translational Biomedicine

  • ISSN: 2172-0479
  • Journal h-index: 18
  • Journal CiteScore: 5.91
  • Journal Impact Factor: 4.11
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • ResearchBible
  • The Global Impact Factor (GIF)
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Electronic Journals Library
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Proquest Summons
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • SHERPA ROMEO
  • Secret Search Engine Labs
  • ResearchGate
  • International Committee of Medical Journal Editors (ICMJE)
Share This Page

Taha Subariya

PhD, Assistant Managing Director, faculty of medicine, Al Arab medical university. Benghazi, Libya

Publications
  • Editorial   
    Antibiotic abuse and development of bacterial resistance.
    Author(s): Taha Subariya*

    The aim of this literature review is to detect the rate of the development of the antibiotic resistant bacteria and the antibiotic abuse by either the healthcare providers or the patients. Antibiotic abuse and the Resistance to antimicrobial agents is a major health problem that affects the whole world, Providing Information on the past state of antimicrobial resistance in Libya may assist the health authorities in addressing and reduce the problem more effectively in the future. Data and information were obtained from 1 article and 5 published studies about Libya by using (PubMed) and (Google scholar) using the terms ?antibiotic resistant bacteria? ?multidrug resistant bacteria in developing countries? ?antibiotic abuse in north Africa? however the data on Libya were very scarce. The term of multidrugresistant (MDR) is defined by the (NIH) as the acquired non susceptibili.. View More»

    Abstract PDF